再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09688 再鼎医药

已收盘 12-05 16:09:08

15.610

-0.070

-0.45%

最高15.680	最低15.430	成交量389.56万
今开15.680	昨收15.680	日振幅1.59%
总市值174.83亿	流通市值174.83亿	总股本11.20亿
成交额6,062万	换手率0.35%	流通股本11.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09688","market":"HK","secType":"STK","nameCN":"再鼎医药","latestPrice":15.61,"timestamp":1764922148007,"preClose":15.68,"halted":0,"volume":3895600,"delay":0,"floatShares":1120000000,"shares":1120000000,"eps":-2.0227704427975337,"marketStatus":"已收盘","change":-0.07,"latestTime":"12-05 16:09:08","open":15.68,"high":15.68,"low":15.43,"amount":60619320,"amplitude":0.015944,"askPrice":15.61,"askSize":17900,"bidPrice":15.6,"bidSize":96600,"shortable":3,"etf":0,"ttmEps":-1.4969094475929503,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"listingDate":1601222400000,"exchange":"SEHK","adjPreClose":15.68,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.52295,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09688","defaultTab":"news","newsList":[{"id":"2589369893","title":"创新药的叙事经济学：叙事即估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2589369893","media":"研究进化论","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589369893?lang=zh_cn&edition=full","pubTime":"2025-12-05 13:26","pubTimestamp":1764912419,"startTime":"0","endTime":"0","summary":"本文从叙事经济学角度来回答这些问题，谈谈估值和策略。这就是创新药估值的极大不确定性，在一个非常宽泛的范围里面波动。创新药行业也有很多叙事，而且由于管线关键节点之间的巨大信息真空期，提供给了叙事情绪很大的发挥空间，而不同的叙事会直接作用到上述DCF模型的各个因子上进而催动估值的大范围波动，对于这些叙事的跟踪和理解就成为了估值的一部分。特别是现在创新药行业大部分贡献估值的管线都还处在未成药的临床阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205135245a7253773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205135245a7253773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1574","06978","LU2488822045.USD","BK1588","BK1161"],"gpt_icon":0},{"id":"2589402852","title":"【券商聚焦】交银国际：医药行业短期催化剂充足 长期继续看好创新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2589402852","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589402852?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:38","pubTimestamp":1764902337,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，2025年10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓从年中起亦呈回落态势，但内外资加大创新药布局的大方向不变。而外资则更积极，聚焦创新主线中的龙头及产业链上游，包括恒瑞医药、君实生物和荣昌生物等创新药，及康龙化成、药明康德和泰格医药等CXO标的。12月，行业仍有充足催化剂，包括各项学术大会、医保谈判结果公布、美联储潜在降息等，板块投资情绪有望稳中有升。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970976","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B543WZ88.USD","LU1251922891.USD","01099","BK1197","BK1500","LU0634319403.HKD","LU1969619763.USD","LU2476274720.SGD","01789","LU0640798160.USD","LU0348766576.USD","IE00BPRC5H50.USD","01530","LU0540923850.HKD","BK1588","LU2476274308.USD","LU0417516571.SGD","BK1585","LU0417516902.SGD","BK1593","BK1141","03329","IE00B5MMRT66.SGD","LU2488822045.USD","LU1303224171.USD","LU2328871848.SGD","09688","LU0348825331.USD","LU2778985437.USD","BK1617","BK1147","02228","BK1583","SG9999014674.SGD","LU2399975544.HKD","LU0417516738.SGD","03933","02367","LU0348827113.USD","02268","LU1794554557.SGD","BK1161","02196","SG9999004311.SGD","LU0588546209.SGD","LU1770034418.SGD","LU0561508036.HKD","06160","09926","HK0000165453.HKD"],"gpt_icon":0},{"id":"1196262606","title":"再鼎医药（9688）公布2025年11月股份变动月报：股本新增2,000,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1196262606","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196262606?lang=zh_cn&edition=full","pubTime":"2025-12-04 19:46","pubTimestamp":1764848775,"startTime":"0","endTime":"0","summary":"再鼎医药有限公司于2025年12月4日发布截至2025年11月30日的股份变动月报。报告显示，公司法定股本维持在50亿股不变。在期权及股权激励方面，2025年11月共行使2,250股来自2022年股权激励计划的期权，皆以公司现有已发行股份结算。另根据2024年股权激励计划，当月新授出721,000股RSU，并由公司发行为奖委托人持有的2,000,000股新股。截至2025年11月底，公司总发行股份数为1,119,628,030股。该份月报由董事杜瑩签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688"],"gpt_icon":0},{"id":"2589861921","title":"每日卖空追踪 | 再鼎医药 12月04日卖空量成交37.71万股，卖空比例为4.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589861921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589861921?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837041,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间12月04日，涨3.29%，卖空量成交37.71万股，较上一交易日减少76.13%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163631a4cc38d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163631a4cc38d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1574","LU2488822045.USD","BK1588","BK1161"],"gpt_icon":0},{"id":"2589861904","title":"再鼎医药12月04日获主力加仓367.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2589861904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589861904?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836143,"startTime":"0","endTime":"0","summary":"12月04日, 再鼎医药股价涨3.29%，报收15.68元，成交金额1.2亿元，换手率0.71%，振幅3.29%，量比1.06。再鼎医药今日主力资金净流入367.0万元，连续6日净流入，上一交易日主力净流入245.2万元。近一年数据显示，该股主力连续6日净流入后，次日上涨概率为28.57%，平均涨幅为2.50%。该股近5个交易日上涨0.58%，主力资金累计净流入999.3万元，其中3个交易日为股价下跌时净流入；近20日主力资金累计净流入1.5亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161925978f7f19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161925978f7f19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1588","09688","BK1574","BK1161"],"gpt_icon":0},{"id":"2588082048","title":"再鼎医药(09688)授出购股权及受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2588082048","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588082048?lang=zh_cn&edition=full","pubTime":"2025-12-03 19:36","pubTimestamp":1764761787,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，于2025年12月1日(美国东部时间)，本公司根据2024年股权激励计划向3名承授人授出可认购合共11,800股美国存托股份的购股权并向6名承授人涉及合共22,665股美国存托股份的受限制股份单位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377221.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK1574","BK4139","BK1588","BK4531","BK4588","09688","BK4548","LU2488822045.USD","BK4526","BK1161","ZLAB"],"gpt_icon":0},{"id":"2588019664","title":"智通港股52周新高、新低统计|12月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2588019664","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588019664?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:40","pubTimestamp":1764751201,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止12月3日收盘，有47只股票创52周新高，其中旅橙文化、滉达富控股、云迹创高率位于前3位，分别为29.58%、12.72%、12.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00204","00550","01044","01107","06603","00213","00363","00517","01119","02650","00598","00300","00215","01176","06960","01208","02276","02431","01341","06616","00693","00765","06980","01348","02443","08627","09878","00412","01146","01268","01380","00115","02405","01451","02587","01274","02579","00513","02477","01373","01397","06626","00341","01842","09688","00548","09956","02670","01258"],"gpt_icon":1},{"id":"2588042401","title":"蒸发千亿市值，器械巨头再次换帅","url":"https://stock-news.laohu8.com/highlight/detail?id=2588042401","media":"CHC医疗传媒","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588042401?lang=zh_cn&edition=full","pubTime":"2025-12-03 15:01","pubTimestamp":1764745299,"startTime":"0","endTime":"0","summary":"此次走马上任的新帅是公司老人。值得注意的是，这已是Novocure约一年内的第二次换帅。2011年，首款经FDA批准的肿瘤电场治疗设备Optune上市，是其重要里程碑。2018年9月，再鼎医药与Novocure达成协议，获得了其肿瘤电场疗法Optune的大中华区权益。2020年，再鼎医疗市值翻倍，Optune成为该公司第二大管线，净收入增长300%。患者在使用前需剃头，将贴片贴在头皮上对准肿瘤位置，在治疗期间定期更换贴片。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203185050a7215a03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203185050a7215a03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","BK1588","LU2488822045.USD","BK1574"],"gpt_icon":0},{"id":"2588532060","title":"每日卖空追踪 | 再鼎医药 12月02日卖空量成交53.92万股，卖空比例为6.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588532060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588532060?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:30","pubTimestamp":1764664238,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间12月02日，跌2.74%，卖空量成交53.92万股，较上一交易日减少12.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163610978b665b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251202163610978b665b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","LU2488822045.USD","BK1588","BK1574"],"gpt_icon":0},{"id":"2586826477","title":"每日卖空追踪 | 再鼎医药 11月26日卖空量成交72.63万股，卖空比例为8.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586826477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586826477?lang=zh_cn&edition=full","pubTime":"2025-11-26 16:30","pubTimestamp":1764145837,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间11月26日，涨0.07%，卖空量成交72.63万股，较上一交易日减少52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163616951b4c77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126163616951b4c77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1588","BK1574","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2585113602","title":"智通港股52周新高、新低统计|11月21日","url":"https://stock-news.laohu8.com/highlight/detail?id=2585113602","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585113602?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:40","pubTimestamp":1763714401,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止11月21日收盘，有14只股票创52周新高，其中恒发光学、朝威控股、木薯资源创高率位于前3位，分别为42.11%、30.56%、22.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02818","09878","06603","00314","06687","09688","01121","00397","02591","01268","01830","01029","01855","00917","02535","01773","00638","00841","01274","01304","02508","02367","02515","00325","00599","02246","06960","03880","00848","01865","00500","02453","02011","00699","02543","01134","00040","01498","02431","01653","02587","00610","01745","00182","01119","00180","00341","01004","08500"],"gpt_icon":1},{"id":"2585014897","title":"每日卖空追踪 | 再鼎医药 11月21日卖空量成交102.38万股，卖空比例为9.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585014897","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585014897?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:30","pubTimestamp":1763713840,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间11月21日，跌4.54%，卖空量成交102.38万股，较上一交易日减少46.66%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163618a708971b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121163618a708971b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1588","LU2488822045.USD","BK1574","BK1161"],"gpt_icon":0},{"id":"2585118598","title":"再鼎医药11月21日遭主力抛售57.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585118598","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585118598?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:15","pubTimestamp":1763712920,"startTime":"0","endTime":"0","summary":"11月21日, 再鼎医药股价跌4.54%，报收15.35元，成交金额1.6亿元，换手率0.95%，振幅2.99%，量比0.97。该股近5个交易日下跌10.29%，主力资金累计净流入419.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2.2亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121161616a7088920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121161616a7088920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU2488822045.USD","09688","BK1161","BK1588"],"gpt_icon":0},{"id":"2585193109","title":"生物医药股全线下跌 荣昌生物(09995)、金斯瑞生物科技(01548)跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585193109","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585193109?lang=zh_cn&edition=full","pubTime":"2025-11-21 11:36","pubTimestamp":1763696200,"startTime":"0","endTime":"0","summary":"金吾财讯 | 生物医药股全线下跌，荣昌生物(09995)跌6.42%，金斯瑞生物科技(01548)跌6.3%，复宏汉霖(02696)跌5.77%，康诺亚-B(02162)跌5.24%，药明生物(02269)跌5.16%，泰格医药(03347)跌4.91%，药明康德(02359)跌4.79%，科伦博泰生物-B(06990)跌4.55%，百济神州(06160)跌4.44%，诺诚健华(09969)跌4.44%，君实生物(01877)跌4.40%，再鼎医药(09688)跌4.17%，康方生物(09926)跌3.98%，药明合联(02268)跌3.76%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/MzdhOTliMTI0NzhlMTgxMzU2MzczNzM1NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/MzdhOTliMTI0NzhlMTgxMzU2MzczNzM1NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970077","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423174.USD","LU0417516902.SGD","03347","06160","LU3063872942.SGD","02268","161726","LU2125910500.SGD","LU0456846285.SGD","09688","SG9999014674.SGD","LU0196878994.USD","BK1587","LU0327786744.USD","BK1574","LU1064131003.USD","LU1242518931.SGD","02269","02696","HK0000320264.USD","IE00BPRC5H50.USD","LU0348784397.USD","399441","LU0516422366.SGD","LU0572944931.SGD","02359","06990","HK0000165453.HKD","LU0516422440.USD","01548","BK1521","688331","LU0516422952.EUR","LU0823426480.USD","LU0348783233.USD","BK1610","01877","LU2328871848.SGD","LU0181495838.USD","09995","LU0456827905.SGD","LU2399975544.HKD","LU1770034418.SGD","LU0140636845.USD","09926","09969","02162","LU0359201612.USD","LU0348766576.USD"],"gpt_icon":0},{"id":"2585711854","title":"每日卖空追踪 | 再鼎医药 11月20日卖空量成交98.5万股，卖空比例为8.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585711854","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585711854?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:30","pubTimestamp":1763627439,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间11月20日，涨1.07%，卖空量成交98.5万股，较上一交易日减少63.09%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163805a706491e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120163805a706491e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1588","09688","BK1161","BK1574"],"gpt_icon":0},{"id":"2584908274","title":"【券商聚焦】中信建投：医药流通行业收入端稳健向好 关注回款及“十五五”规划","url":"https://stock-news.laohu8.com/highlight/detail?id=2584908274","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584908274?lang=zh_cn&edition=full","pubTime":"2025-11-20 09:20","pubTimestamp":1763601625,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研报指，中药行业短期基数压力有望缓解，渠道库存加速出清，看好年底需求回暖，及后续基本面和估值改善机会；创新领域有助构建第二增长曲线，中药消费品公司品牌延展空间广阔。血制品行业关注“十五五”浆站建设规划及行业并购整合进展，需求端看好静丙、因子类产品需求端提升及新品研发。疫苗行业关注重磅产品销售改善情况及创新管线研发进展，政策出台及疫苗出海有望推动企业进一步发展。医药零售行业转型变革稳步推进，关注后续多元催化。医药流通行业收入端稳健向好，关注回款及“十五五”规划。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YmUwNDEzZDkyZTQxMjdjZGQ1ZTFlYjEwODUyNTc4Njg4Nw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969973","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348767384.USD","LU0640798160.USD","BK1585","LU0417516571.SGD","BK1574","01789","LU0561508036.HKD","LU2476274308.USD","BK0276","LU1961090484.USD","03933","LU0348825331.USD","LU0588546209.SGD","159938","01099","LU1251922891.USD","BK1583","LU0417516738.SGD","02196","09939","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","BK1100","IE00B543WZ88.USD","LU2476274720.SGD","02268","LU1303224171.USD","LU2399975544.HKD","BK1191","02367","LU1969619763.USD","BK1593","BK1515","LU0540923850.HKD","LU0307460666.USD","01530","LU1719994722.HKD","06160","LU0348766576.USD","09688","02228","LU2328871848.SGD","09926","601066","BK1197","BK1500","BK1617","IE00B5MMRT66.SGD","LU0417516902.SGD"],"gpt_icon":0},{"id":"2584945044","title":"再鼎医药(09688)根据股权激励计划发行200万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584945044","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584945044?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:13","pubTimestamp":1763554404,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，于2025年11月19日，该公司发行200万股新股，由受托人持有，以兑现按先前披露的条款(1)归属根据 2017，2022及2024年股权激励计划所授出的股份奖励，及(2)如适用，行使根据2015，2017，2022及2024年股权激励计划所授出的期权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4548","ZLAB","BK4531","LU2488822045.USD","BK1588","BK4139","BK4585","BK1161","BK4588","09688","BK4526","BK1574"],"gpt_icon":0},{"id":"2584919864","title":"智通港股52周新高、新低统计|11月19日","url":"https://stock-news.laohu8.com/highlight/detail?id=2584919864","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584919864?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:40","pubTimestamp":1763541601,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止11月19日收盘，有28只股票创52周新高，其中怡俊集团控股、威发国际股权、澳达控股创高率位于前3位，分别为113.27%、19.23%、18.52%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["00314","00108","02698","02385","01855","02521","01982","00610","00257","00915","02543","02579","03737","01238","09608","00182","09688","00873","03700","01739","06939","00040","00152","02442","02246","01653","02562","00884","00670","00917","06687","00535","00321","00638","01959","03708","00841","01233","01268","02011","02495","00341","01745","00133","02098","00699","00363","01773","02651"],"gpt_icon":0},{"id":"2584539945","title":"每日卖空追踪 | 再鼎医药 11月19日卖空量成交116.65万股，卖空比例为9.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584539945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584539945?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:30","pubTimestamp":1763541037,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间11月19日，涨0.25%，卖空量成交116.65万股，较上一交易日减少21.26%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163618a4ac524e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119163618a4ac524e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1574","BK1588","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2584945370","title":"再鼎医药11月19日获主力加仓377.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584945370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584945370?lang=zh_cn&edition=full","pubTime":"2025-11-19 16:15","pubTimestamp":1763540142,"startTime":"0","endTime":"0","summary":"11月19日, 再鼎医药股价涨0.25%，报收15.91元，成交金额1.9亿元，换手率1.11%，振幅3.28%，量比1.10。再鼎医药今日主力资金净流入377.9万元，连续3日净流入，上一交易日主力净流入821.7万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为43.75%，平均涨幅为2.06%。该股近5个交易日下跌6.78%，主力资金累计净流入2912.1万元；近20日主力资金累计净流入1.9亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119161928a4ac46d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119161928a4ac46d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","BK1574","BK1161","LU2488822045.USD","09688"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.2396},{"period":"3month","weight":-0.3515},{"period":"6month","weight":-0.4712},{"period":"1year","weight":-0.3212},{"period":"ytd","weight":-0.2498}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"再鼎医药有限公司是一家主要从事生物制药的控股公司。该公司致力于通过产品的发现、开发和商业化解决肿瘤、自身免疫疾病、感染性疾病和中枢神经系统疾病领域未被满足的医疗需求。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物。其中包括“则乐”、“OPTUNE”、“擎乐”、“纽再乐”及“卫伟迦”等。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.013207},{"month":2,"riseRate":0.6,"avgChangeRate":0.053227},{"month":3,"riseRate":0.2,"avgChangeRate":-0.100669},{"month":4,"riseRate":0.6,"avgChangeRate":0.032813},{"month":5,"riseRate":0.4,"avgChangeRate":-0.024133},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013792},{"month":7,"riseRate":0.8,"avgChangeRate":0.065752},{"month":8,"riseRate":0.6,"avgChangeRate":-0.021717},{"month":9,"riseRate":0.4,"avgChangeRate":-0.054178},{"month":10,"riseRate":0.5,"avgChangeRate":-0.051338},{"month":11,"riseRate":0.5,"avgChangeRate":0.047251},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.003095}],"exchange":"SEHK","name":"再鼎医药","nameEN":"ZAI LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,09688,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}